Jul 2026· Public Health Risk Assesment Journal· 0 citations· 54 references
Abstract
Background: Ambient particulate matter ≤2.5 μm (PM2.5) is a major environmental health risk contributing to global morbidity and mortality. Although its link with cardiovascular diseases is well established, evidence on the stroke burden attributable to PM2.5 exposure remains limited in Indonesia. Methods: This ecological study used Global Burden of Disease (GBD) 2021 data to analyze the association between PM2.5 exposure and stroke burden, including incidence, prevalence, and mortality, across 34 Indonesian provinces from 2011 to 2020. Age-standardized rates (ASRs) were assessed using a linear mixed model, with year as a repeated measure and province as a random effect to account for spatial and temporal variations. Findings: Mean PM2.5 concentrations ranged from 16.96 to 20.10 µg/m³, exceeding WHO and national air quality standards. Despite minor annual fluctuations in PM2.5, stroke mortality attributable to air pollution showed an increasing trend. Higher PM2.5 levels were significantly associated with ischemic stroke (IS) incidence (β = -0.117, p <0.001) and mortality (β = 0.152, p <0.001), as well as intracerebral hemorrhage (ICH) incidence (β = 0.017, p = 0.015), prevalence (β = 1.641, p <0.001), and mortality (β = 0.773, p = 0.004). The effect of PM2.5 exposure was greater for ICH than for IS. Conclusion: Long-term exposure to PM2.5 is significantly associated with stroke burden in Indonesia, particularly for ICH. Strengthening air quality management and stroke prevention policies is crucial, especially in high-risk regions. Novelty/Originality of this article: This study is the first to comprehensively assess the long-term association between PM2.5 and stroke subtypes using national-level GBD data across all Indonesian provinces, providing spatially and temporally robust evidence for public health policy in low- and middle-income tropical settings.
The findings indicate that extreme pollution events pose a new and growing threat to global public health, demanding a shift in policy from managing annual average concentrations to focusing on early warning and intervention for extreme pollution peaks.
Jian-Yu Deng, Peng Zhou, Jinting Guo et al.· The Innovation Medicine· 0 citations
The spatiotemporal variability of fine particulate matter in Addis Ababa, Ethiopia and its associated health risks and economic burden are investigated to support targeted policies aimed at reducing PM2.5 related cancers.
Background: Fine particulate matter (PM2.5) remains a major environmental health concern, particularly in low- and middle-income countries. Nigeria experiences persistently high ambient PM2.5 exposure, yet long-term national evidence linking annual exposure patterns with broad population-health indicators remains limit...
J. Kalu· IPS Journal of Public Health· 0 citations
Long-term exposure to ambient fine particulate matter (PM2.5) is the leading environmental risk factor for premature mortality worldwide, yet comprehensive province-level evidence quantifying its health burden across Türkiye remains limited. This study investigated the spatial relationship between long-term PM2.5 expos...
Background/Objectives: Stroke remains a leading cause of death and disability globally, with considerable regional heterogeneity in incidence and mortality reflecting differences in classical vascular risk factors and environmental determinants. Fine particulate matter (PM2.5) is an established modifiable environmental...
J. Ramírez-Moreno, Víctor Martín Hernández, Andrea Parejo Olivera et al.· Medical Science· 0 citations
Objectives Ambient air pollution, particularly fine particulate matter (PM2.5), has been linked to cerebrovascular disease. However, findings on the short-term effects of PM2.5 exposure on hemorrhagic stroke (HS) have been inconsistent across studies. Therefore, this study investigated the association between short-ter...
K. Qian, Xiao-Rong Xu, Chun-Xiang Xu et al.· Frontiers in Public Health· 0 citations
We use cookies to run the site and, with your consent, for analytics and to show ads.
See our Cookie Policy.